28 unchanged sentences
Our internal control over financial reporting is designed to provide
−Removed: reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for
−Removed: external reporting purposes in accordance with U.S.
−Removed: Our internal control over financial reporting includes those policies and procedures
+Added: reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting
+Added: purposes in accordance with U.S.
+Added: Our internal control over financial reporting includes those policies and procedures that:
to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the
4 unchanged sentences
could have a material effect on the financial statements.
−Removed: of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our financial statements.
−Removed: Also, projections of any evaluation of effectiveness to future periods are subject to the risk
−Removed: that controls may become inadequate because of changes in conditions, or that the degree or compliance with the policies or
−Removed: procedures may deteriorate.
−Removed: Management assessed the effectiveness of our internal control over financial reporting as of December
−Removed: In making these assessments, management used the criteria set forth by the Committee of Sponsoring Organizations of the
−Removed: Treadway Commission in Internal Control — Integrated Framework (2013).
−Removed: Based on our assessments and those criteria, management
−Removed: determined that we did not maintain effective internal control over financial reporting as of December 31, 2024 ,
−Removed: due to the material weakness in our internal controls as a result of inadequate segregation of duties within accounting processes
−Removed: due to limited personnel and insufficient written policies and procedures for accounting, IT, and financial reporting and record
−Removed: This Annual Report does not include an attestation
−Removed: report by our independent registered public accounting firm, regarding internal control over financial reporting.
−Removed: As a smaller reporting
−Removed: company, our management’s report was not subject to attestation by our registered public accounting firm pursuant to rules of the
−Removed: SEC that permit us to provide only management’s report in this Annual Report.
+Added: of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our financial
+Added: Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
+Added: because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate.
+Added: Management assessed
+Added: the effectiveness of our internal control over financial reporting as of December 31, 2025.
+Added: In making these assessments, management used
+Added: the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control — Integrated
+Added: Framework (2013).
+Added: Based on our assessments and those criteria, management determined that we did not maintain effective internal control
+Added: over financial reporting as of December 31, 2025, due to the material weakness in our internal
+Added: controls as a result of inadequate segregation of duties within accounting processes due to limited personnel and insufficient written
+Added: policies and procedures for accounting, IT, and financial reporting and record keeping.
+Added: intends to implement remediation steps to improve our internal controls due to inadequate segregation of duties within account processes
+Added: due to limited personnel and insufficient written policies and procedures for accounting, IT, and financial reporting and record keeping.
+Added: We plan to further improve this process by enhancing the size and composition of our board of directors upon the closing of the business
+Added: and to identify third-party professionals with whom to consult regarding complex accounting applications and consideration of additional
+Added: staff with the requisite experience and training to supplement existing accounting professionals and implemented additional layers of
+Added: reviews in the financial close process.
+Added: Annual Report does not include an attestation report by our independent registered public accounting firm, regarding internal control
+Added: over financial reporting.
+Added: As a smaller reporting company, our management’s report was not subject to attestation by our registered
+Added: public accounting firm pursuant to rules of the SEC that permit us to provide only management’s report in this Annual Report.
in Internal Control Over Financial Reporting
6 unchanged sentences
following table sets forth information about our directors and executive officers.
−Removed: Chief Executive
−Removed: Officer, Secretary, and Director
−Removed: Heung Ming Wong
−Removed: Chief Financial Officer
−Removed: Independent Director
−Removed: Independent Director
−Removed: Independent Director
+Added: Executive Officer, Secretary, and Director
+Added: Financial Officer and Director
Xie, CEO, Secretary, and Director
159 unchanged sentences
Karlsen is well-qualified to serve as a member of our board of directors due to his extensive cross-border business
−Removed: experience., as well as her network of contacts and relationships.
+Added: experience., as well as his network of contacts and relationships.
requires that a majority of our board must be composed of “independent directors,” which is defined generally as a person
43 unchanged sentences
Karlsen and Julianne Huh are independent.
−Removed: of the audit committee is financially literate and our board of directors has determined that Lin Bao qualifies as an “audit committee
−Removed: financial expert” as defined in applicable SEC rules.
+Added: member of the audit committee is financially literate and our board of directors has determined that Lin Bao qualifies as an “audit
+Added: committee financial expert” as defined in applicable SEC rules.
Responsibilities
86 unchanged sentences
received within a lookback period of the three completed fiscal years preceding the date on which we are required to prepare an accounting
+Added: restatement .
foregoing description of the Clawback Policy does not purport to be complete and is qualified in its entirety by the terms and conditions
119 unchanged sentences
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
−Removed: following table sets forth the number of our ordinary shares beneficially owned, as of March 28, 2025 by (i) each person who is
−Removed: known by us to be the beneficial owner of more than five percent of our issued and outstanding ordinary shares;
−Removed: (ii) each of our officers
−Removed: and directors;
+Added: following table sets forth the number of our ordinary shares beneficially owned, as of May 4, 2026 by (i) each person who is known
+Added: by us to be the beneficial owner of more than five percent of our issued and outstanding ordinary shares;
+Added: (ii) each of our officers and
and (iii) all of our officers and directors as a group.
−Removed: As of March 28, 2025, we had 6,121,733 ordinary shares issued
−Removed: and outstanding.
+Added: As of May 4, 2026, we had 3,166,332 ordinary shares issued and
otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to the ordinary
shares beneficially owned by them.
−Removed: and Address of Beneficial Owner (1)
−Removed: of Shares Beneficially Owned (2)
−Removed: Percentage of
−Removed: Outstanding Shares
+Added: Name and Address of Beneficial Owner (1)
+Added: Number of Shares Beneficially Owned (2)
+Added: Percentage of Outstanding Shares
Heung Ming Wong
Juan Fernandez Pascual (3)
−Removed: and directors as a group
+Added: All officers and directors as a group
(6 individuals)
1 unchanged sentence
Aimei Investment Ltd (4)
−Removed: First Trust Merger Arbitrage
−Removed: First Trust Capital Management
−Removed: Wolverine Asset Management,
−Removed: Karpus Investment Management (8)
than one percent.
11 unchanged sentences
(Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, George Town, Cayman Islands.
−Removed: on a Schedule 13G filed on November 14, 2024.
−Removed: The schedule was filed jointly by First Trust Merger Arbitrage Fund (“VARBX”),
−Removed: First Trust Capital Management L.P.
−Removed: (“FTCM”), First Trust Capital Solutions L.P.
−Removed: (“FTCS”) and FTCS Sub GP
−Removed: LLC (“Sub GP”).
−Removed: FTCM is an investment adviser registered with the SEC that provides investment advisory services to,
−Removed: among others, (i) series of Investment Managers Series Trust II, an investment company registered under the Investment Company Act
−Removed: of 1940, specifically First Trust Multi-Strategy Fund and VARBX, (ii) First Trust Alternative Opportunities Fund, an investment company
−Removed: registered under the Investment Company Act of 1940, and (iii) Highland Capital Management Institutional Fund II, LLC, a Delaware
−Removed: limited liability company (collectively, the “Client Accounts”).
−Removed: FTCS is a Delaware limited partnership and control person
−Removed: Sub GP is a Delaware limited liability company and control person of FTCM.
−Removed: VARBX is a series of Investment Managers Series
−Removed: Trust II, an investment company registered under the Investment Company Act of 1940.
−Removed: As investment adviser to the Client Accounts,
−Removed: FTCM has the authority to invest the funds of the Client Accounts in securities (including our ordinary shares) as well as the authority
−Removed: to purchase, vote and dispose of securities, and may thus be deemed the beneficial owner of the ordinary shares of our Company held
−Removed: in the Client Accounts.
−Removed: According to the schedule, Joy Ausili is the Trustee, Vice President and Assistant Secretary of VARBX.
−Removed: principal business address of VARBX is 235 West Galena Street, Milwaukee, WI 53212.
−Removed: on a Schedule 13G filed on November 14, 2024.
−Removed: The schedule was filed jointly by First Trust Merger Arbitrage Fund (“VARBX”),
−Removed: First Trust Capital Management L.P.
−Removed: (“FTCM”), First Trust Capital Solutions L.P.
−Removed: (“FTCS”) and FTCS Sub GP
−Removed: LLC (“Sub GP”).
−Removed: FTCM is an investment adviser registered with the SEC that provides investment advisory services to,
−Removed: among others, (i) series of Investment Managers Series Trust II, an investment company registered under the Investment Company Act
−Removed: of 1940, specifically First Trust Multi-Strategy Fund and VARBX, (ii) First Trust Alternative Opportunities Fund, an investment company
−Removed: registered under the Investment Company Act of 1940, and (iii) Highland Capital Management Institutional Fund II, LLC, a Delaware
−Removed: limited liability company.
−Removed: FTCS is a Delaware limited partnership and control person of FTCM.
−Removed: Sub GP is a Delaware limited liability
−Removed: company and control person of FTCM.
−Removed: FTCS and Sub GP may be deemed to control FTCM and therefore may be deemed to be beneficial owners
−Removed: of the ordinary shares owned by FTCM.
−Removed: According to the schedule, Chad Eisenberg is the chief operating officer of FTCM, FTCS, and
−Removed: The principal business address of FTCM, FTCS and Sub GP is 225 W.
−Removed: Wacker Drive, 21st Floor, Chicago, IL 60606.
−Removed: on a Schedule 13G filed on October 16, 2024 and a Schedule 13G/A filed on January 31, 2025.
−Removed: The schedule relates to shares owned
−Removed: by Wolverine Asset Management, LLC (“WAM”).
−Removed: The sole member and manager of WAM is Wolverine Holdings, L.P.
−Removed: Bellick and Christopher L.
−Removed: Gust may be deemed to control Wolverine Trading Partners, Inc., the general
−Removed: partner of Wolverine Holdings.
−Removed: The address of the principal business office of WAM is 175 West Jackson Boulevard, Suite 340, Chicago,
−Removed: on a Schedule 13G filed on April 9, 2024.
−Removed: Karpus Investment Management (“Karpus”) is controlled by City of London Investment
−Removed: Group plc (“CLIG”), which is listed on the London Stock Exchange.
−Removed: However, in accordance with SEC Release No.
−Removed: (January 12, 1998), effective informational barriers have been established between Karpus and CLIG such that voting and investment
−Removed: power over the subject securities is exercised by Karpus independently of CLIG, and, accordingly, attribution of beneficial ownership
−Removed: is not required between Karpus and CLIG.
−Removed: The address of the principal business office for Karpus is 183 Sully’s Trail, Pittsford,
−Removed: New York 14534.
Certain Relationships and Related Transactions, and Director Independence.
24 unchanged sentences
the right to exchange their ordinary shares for cash, securities or other property.
−Removed: Note — Related Party
−Removed: May 1, 2023, the Sponsor issued an unsecured promissory note to us, pursuant to which we may borrow up to an aggregate principal amount
−Removed: of $750,000, to be used for payment of costs related to the IPO.
−Removed: The note is non-interest bearing and payable on the earlier of (i) December
−Removed: 31, 2023, (ii) the consummation of the IPO, or (iii) the date on which we determine to not proceed with the IPO.
−Removed: As of December 6, 2023,
−Removed: we had borrowed $210,151 under the promissory note with the Sponsor.
−Removed: This promissory note was fully repaid on December 7, 2023.
−Removed: was no balance due as of December 31, 2024.
Loan — Related Party
−Removed: December 11, 2024 and January 13, 2025, the Sponsor and United Hydrogen caused the first and second monthly extension fee of $227,700
−Removed: (equivalent to $0.033 per Public Share), respectively, to be deposited into the Trust Account, to extend the date by which we have to
−Removed: consummate a business combination from December 6, 2024 to February 6, 2025.
−Removed: On February 6, 2025 and March 6, 2025, the Sponsor and United
−Removed: Hydrogen caused the third and fourth monthly extension fee of $150,000, respectively, to be deposited into the Trust Account, to further
−Removed: extend the deadline from February 6, 2024 to April 6, 2025.
−Removed: The deposit of the first, second, third, and fourth monthly extension fee
−Removed: is evidenced by an unsecured promissory note (each, a “Monthly Extension Promissory Note”).
−Removed: The first and second Monthly
−Removed: Extension Promissory Notes are in the principal amount of $227,700 each, shared equally between the Sponsor and United Hydrogen ($113,850
−Removed: The third and fourth Monthly Extension Promissory Notes are in the principal amount of $150,000, also shared equally between the
−Removed: Sponsor and United Hydrogen ($75,000 each).
−Removed: Each Monthly Extension Promissory Note bears no interest and is payable in full upon the
−Removed: consummation of the Business Combination.
−Removed: The Sponsor and United Hydrogen have the right, but not the obligation, to convert the Monthly
−Removed: Extension Promissory Note, in whole or in part, into our private units, at a price of $10.00 per unit, each consisting of one ordinary
−Removed: share and one right to receive one-fifth (1/5) of one ordinary share of our Company, immediately prior to the consummation of the Business
−Removed: Combination, by providing us with written notices of their intention to convert the Monthly Extension Promissory Note at least two business
−Removed: days prior to the closing of the Business Combination.
−Removed: As of December 31, 2024 and 2023, the note payable balance was $227,700 and $0,
+Added: to the amended and restated memorandum and articles of association of the Company then in effect, if the Company anticipates that it
+Added: may not be able to consummate a business combination within 12 months of the closing of the IPO, the Company may extend the period of
+Added: time to consummate a business combination up to twelve times by an additional one month each time to complete a business combination.
+Added: Pursuant to the terms of the Company’s memorandum and articles of association and the trust agreement entered into between the
+Added: Company and the Trustee, both as amended, in order to extend the time available for the Company to consummate a business combination,
+Added: the Sponsor its affiliates or designees, upon five days advance notice prior to the applicable deadline, must deposit into the Trust
+Added: Account the applicable extension fees, on or prior to the date of the applicable deadline, for each extension.
+Added: The Sponsor or its affiliates
+Added: or designees will receive a non-interest bearing, unsecured promissory note equal to the amount of any such deposit that will not be
+Added: repaid in the event that the Company is unable to close a business combination unless there are funds available outside the Trust Account
+Added: Such notes would either be paid upon consummation of the Company’s initial business combination or at the lender’s
+Added: discretion, converted upon consummation of the business combination into additional private units at a price of $10.00 per unit.
+Added: the year ended December 31, 2025 and 2024, the Company entered into monthly extension loans with its Sponsor for $1,012,031 and $113,850,
+Added: respectively, and United Hydrogen for $1,012,031 and $113,850, respectively;
+Added: these funds are deposited into the Trust Account in order
+Added: to extend the time available to complete a business combination.
+Added: These loans are non-interest bearing, payable upon the closing of a
+Added: business combination, and convertible at the lender’s discretion, upon consummation of the business combination, into additional
+Added: private units at a price of $10.00 per unit.
+Added: As of December 31, 2025 and 2024, the extension loan balances were $2,024,062 and $227,700,
respectively.
21 unchanged sentences
to Related Company
−Removed: of December 31, 2024 and 2023, the Company had a total amount due to related company of $289,780 and $0, from a related party, respectively,
−Removed: for the payment of costs related to general and administrative services, the Initial Public Offering, and administrative services agreement.
−Removed: The balance of which $50,000 was deposited in the Trust Account as of December 31, 2024 for the January 13, 2025 extension payment.
−Removed: balance is unsecured, interest-free and has no fixed terms of repayment.
+Added: of December 31, 2025 and 2024, the Company had a total amount due to a related company of $899,601 and $289,780, from a related party,
+Added: respectively, for the payment of costs related to general and administrative services, the Initial Public Offering, and administrative
+Added: services agreement.
+Added: The balance is unsecured, interest-free and has no fixed terms of repayment.
ongoing and future transactions between us and any member of our management team or his or her respective affiliates will be on terms
21 unchanged sentences
for professional services rendered for the audit of our annual financial statements, review of the financial information included in
−Removed: our required filings with the SEC for the year ended December 31, 2024 and for the period from April 27, 2023 (inception) through December
−Removed: 31, 2023 totaled $160,000 and $115,000, respectively.
−Removed: The above amounts include interim procedures and audit fees, as well as attendance
−Removed: at audit committee meetings.
+Added: our required filings with the SEC for the years ended December 31, 2025 and 2024 totaled $130,000 and $160,000, respectively.
+Added: amounts include interim procedures and audit fees, as well as attendance at audit committee meetings.
Audit-Related
2 unchanged sentences
services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards.
−Removed: did not pay MaloneBailey for consultations concerning financial accounting and reporting standards for the period for the year ended
−Removed: December 31, 2024 and for the period from April 27, 2023 (inception) through December 31, 2023.
−Removed: We did not pay MaloneBailey for tax planning and tax advice for the year ended December 31, 2024 and for the period from April
−Removed: 27, 2023 (inception) through December 31, 2023.
−Removed: We did not pay MaloneBailey for other services for the year ended December 31, 2024 and for the period from April 27,
−Removed: 2023 (inception) through December 31, 2023.
+Added: did not pay MaloneBailey for consultations concerning financial accounting and reporting standards for the years ended December 31, 2025
+Added: We did not pay MaloneBailey for tax planning and tax advice for the years ended December 31, 2025 and 2024.
+Added: We did not pay MaloneBailey for other services for the years ended December 31, 2025 and 2024.
audit committee was formed in connection with the effectiveness of our registration statement for our IPO.
25 unchanged sentences
Rights Agreement, dated December 1, 2023, by and between Continental Stock Transfer & Trust Company and the Registrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by the Registrant on December 6, 2023)
−Removed: Description of Securities
+Added: Description of Securities (incorporated by reference to Exhibit 4.5 to the Annual Report on Form 10-K filed by the Registrant on March 25, 2024)
Letter Agreement, dated December 1, 2023, among the Registrant and the Registrant’s officers, directors and Initial Stockholders (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the Registrant on December 6, 2023)
7 unchanged sentences
Form of Seller Shareholder Support Agreement (Incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the Registrant on June 20, 2024)
−Removed: Founder Support Agreement, dated June 19, 2024
+Added: Founder Support Agreement, dated June 19, 2024 (incorporated by reference to Exhibit 10.10 to the Annual Report on Form 10-K filed by the Registrant on March 28, 2025)
Form of Seller Lock-Up Agreement (Incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed by the Registrant on June 20, 2024)
1 unchanged sentence
Form of Code of Ethics (incorporated by reference to Exhibit 14 filed with the Registration Statement on Form S-1/A filed by the Registrant on July 24, 2023)
−Removed: List of Subsidiaries
+Added: of Subsidiaries
Power of Attorney (included on the signature page to this Annual Report on Form 10-K).
9 unchanged sentences
Nominating Committee Charter (incorporated by reference to Exhibit 99.1 to the Registration Statement on Form S-1/A filed by the Registrant on July 24, 2023)
−Removed: Inline XBRL Instance Document.
−Removed: Inline XBRL Taxonomy Extension
−Removed: Schema Document.
−Removed: Inline XBRL Taxonomy Extension
−Removed: Calculation Linkbase Document.
−Removed: Inline XBRL Taxonomy Extension
−Removed: Definition Linkbase Document.
−Removed: Inline XBRL Taxonomy Extension
−Removed: Label Linkbase Document.
−Removed: Inline XBRL Taxonomy Extension
−Removed: Presentation Linkbase Document.
−Removed: Cover Page Interactive
−Removed: Data File (formatted as Inline XBRL and contained in Exhibit 101).
+Added: XBRL Instance Document.
+Added: XBRL Taxonomy Extension Schema Document.
+Added: XBRL Taxonomy Extension Calculation Linkbase Document.
+Added: XBRL Taxonomy Extension Definition Linkbase Document.
+Added: XBRL Taxonomy Extension Label Linkbase Document.
+Added: XBRL Taxonomy Extension Presentation Linkbase Document.
+Added: Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No.
34-47986, the certifications furnished in Exhibits 32.1
−Removed: and 32.2 herewith are deemed to accompany this Form 10-Q and will not be deemed filed for purposes of Section 18 of the Exchange
+Added: and 32.2 herewith are deemed to accompany this Form 10-K and will not be deemed filed for purposes of Section 18 of the Exchange
Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange
+Added: Form 10-K Summary.
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
1 unchanged sentence
Health Technology Co., Ltd
−Removed: March 28, 2025
Executive Officer
25 unchanged sentences
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
−Removed: To the Shareholders and Board of Directors of
−Removed: Aimei Health Technology Co., Ltd.
−Removed: Opinion on the Financial Statements
−Removed: We have audited the accompanying balance
−Removed: sheets of Aimei Health Technology Co., Ltd.
−Removed: (the “Company”) as of December 31, 2024 and 2023, and the related statements of
−Removed: operations, changes in shareholders’ deficit, and cash flows for the year ended December 31, 2024, and for the period from April
−Removed: 27, 2023 (inception) through December 31, 2023 , and the related notes (collectively referred to as the “financial statements”).
−Removed: In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
−Removed: 31, 2024 and December 31, 203, and the results of its operations and its cash flows for the year ended December 31, 2024, and for the
−Removed: period from April 27, 2023 (inception) through December 31, 2023, in conformity with accounting principles generally accepted in the United
+Added: the Shareholders and Board of Directors of
+Added: Health Technology Co., Ltd.
+Added: on the Financial Statements
+Added: have audited the accompanying balance sheets of Aimei Health Technology Co., Ltd.
+Added: (the “Company”) as of December 31, 2025
+Added: and 2024 , and the related statements of operations, changes in shareholders’ deficit, and cash flows for the years then ended,
+Added: and the related notes (collectively referred to as the “financial statements”).
+Added: In our opinion, the financial statements
+Added: present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of
+Added: its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United
States of America.
−Removed: Going Concern Matter
−Removed: The accompanying financial statements have
−Removed: been prepared assuming that the Company will continue as a going concern.
−Removed: As discussed in Note 1 to the financial statements, the Company’s
−Removed: business plan is dependent on the completion of a business combination within a prescribed period of time and if not completed will cease
−Removed: all operations except for the purpose of liquidating.
−Removed: The date for mandatory liquidation and subsequent dissolution raises substantial
−Removed: doubt about the Company’s ability to continue as a going concern.
−Removed: Management’s plans in regard to these matters are also described
−Removed: The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
−Removed: Basis for Opinion
−Removed: These financial statements are the responsibility
−Removed: of the Company’s management.
−Removed: Our responsibility is to express an opinion on the Company’s financial statements based on our
−Removed: We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”)
−Removed: and are required to be independent with respect to the Company in accordance with the U.S.
−Removed: federal securities laws and the applicable
−Removed: rules and regulations of the Securities and Exchange Commission and the PCAOB.
−Removed: We conducted our audits in accordance with
−Removed: the standards of the PCAOB.
−Removed: Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the
−Removed: financial statements are free of material misstatement, whether due to error or fraud.
−Removed: The Company is not required to have, nor were we
−Removed: engaged to perform, an audit of its internal control over financial reporting.
−Removed: As part of our audits we are required to obtain an understanding
−Removed: of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s
−Removed: internal control over financial reporting.
+Added: Concern Matter
+Added: accompanying financial statements have been prepared assuming that the Company will continue as a going concern.
+Added: As discussed in Note
+Added: 1 to the financial statements, the Company’s business plan is dependent on the completion of a business combination within a prescribed
+Added: period of time and if not completed will cease all operations except for the purpose of liquidating.
+Added: The date for mandatory liquidation
+Added: and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern.
+Added: plans in regard to these matters are also described in Note 1.
+Added: The financial statements do not include any adjustments that might result
+Added: from the outcome of this uncertainty.
+Added: financial statements are the responsibility of the Company’s management.
+Added: Our responsibility is to express an opinion on the Company’s
+Added: financial statements based on our audits.
+Added: We are a public accounting firm registered with the Public Company Accounting Oversight Board
+Added: (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S.
+Added: securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
+Added: conducted our audits in accordance with the standards of the PCAOB.
+Added: Those standards require that we plan and perform the audits to obtain
+Added: reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
+Added: is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.
+Added: As part of our audits
+Added: we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
+Added: on the effectiveness of the Company’s internal control over financial reporting.
Accordingly, we express no such opinion.
−Removed: Our audits included performing procedures
−Removed: to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that
−Removed: respond to those risks.
−Removed: Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial
−Removed: Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as
−Removed: evaluating the overall presentation of the financial statements.
−Removed: We believe that our audits provide a reasonable basis for our opinion.
−Removed: /s/ MaloneBailey, LLP
+Added: audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
+Added: or fraud, and performing procedures that respond to those risks.
+Added: Such procedures included examining, on a test basis, evidence regarding
+Added: the amounts and disclosures in the financial statements.
+Added: Our audits also included evaluating the accounting principles used and significant
+Added: estimates made by management, as well as evaluating the overall presentation of the financial statements.
+Added: We believe that our audits
+Added: provide a reasonable basis for our opinion.
+Added: MaloneBailey, LLP
www.malonebailey.com
−Removed: We have served as the Company’s auditor
−Removed: Houston, Texas
−Removed: March 28, 2025
+Added: have served as the Company’s auditor since 2023.
HEALTH TECHNOLOGY CO., LTD
+Added: As of December 31,
Current assets:
2 unchanged sentences
Cash held in Trust Account
−Removed: TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT
+Added: LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT
Current liabilities:
−Removed: loan – related party
+Added: Accrued expenses
+Added: Extension loans – related party
Due to a related company
Total current liabilities
−Removed: Deferred underwriter
+Added: Deferred underwriter fee payable
TOTAL LIABILITIES
Commitments and contingencies (Note 7)
−Removed: Ordinary shares, subject
−Removed: to possible redemption.
−Removed: 6,900,000 and 6,900,000 shares issued and outstanding at redemption value of $ 10.69 and $ 10.13 as of December
−Removed: 31, 2024 and 2023, respectively
+Added: Ordinary shares, subject to possible redemption.
+Added: 1,040,332 and 6,900,000 shares issued and outstanding at redemption value of $ 11.63 and $ 10.69 as of December 31, 2025 and 2024, respectively
Shareholders’ deficit:
−Removed: Ordinary shares, $ 0.0001
+Added: Ordinary shares, $ 0.0001 par value;
500,000,000 shares authorized;
−Removed: 2,126,000 and 2,126,000 shares issued and outstanding as of December 31, 2024 and 2023,
−Removed: respectively (excluding 6,900,000 and 6,900,000 shares subject to possible redemption, respectively)
+Added: 2,126,000 and 2,126,000 shares issued and outstanding as of December 31, 2025 and 2024, respectively (excluding 1,040,332 and 6,900,000 shares subject to possible redemption, respectively)
Accumulated deficit
( 4,058,944 )
+Added: ( 1,476,823 )
Total shareholders’ deficit
( 4,058,731 )
−Removed: LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT
+Added: ( 1,476,610 )
+Added: TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT
accompanying notes are an integral part of these financial statements.
1 unchanged sentence
OF OPERATIONS
−Removed: ended December 31,
−Removed: the period from April 27, 2023 (inception) through December 31,
−Removed: and operating costs
+Added: For the Years Ended December 31,
+Added: General, administrative and operational costs
$ ( 835,759 )
−Removed: from operations
$ ( 1,064,786 )
−Removed: earned on assets held in trust
−Removed: and diluted weighted average shares outstanding, ordinary shares subject to possible redemption
−Removed: and diluted net income per ordinary shares subject to possible redemption
−Removed: and diluted weighted average shares outstanding, ordinary shares attributable to not subject to possible redemption
−Removed: and diluted net income per share, ordinary shares attributable to not subject to possible redemption
+Added: Loss from operations
+Added: ( 1,064,786 )
+Added: Other income:
+Added: Interest earned on cash held in trust
+Added: Total other income, net
+Added: Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption
+Added: Basic and diluted net income per ordinary share subject to possible redemption
+Added: Basic and diluted weighted average shares outstanding, ordinary shares attributable to not subject to possible redemption
+Added: Basic and diluted net income per share, ordinary shares attributable to not subject to possible redemption
accompanying notes are an integral part of these financial statements.
1 unchanged sentence
OF CHANGES IN SHAREHOLDERS’ DEFICIT
−Removed: Ended December 31, 2024
−Removed: Stockholders’
−Removed: as of December 31, 2023
+Added: For the Year Ended December 31, 2025
+Added: Ordinary shares
+Added: Shareholders’
+Added: Balance as of December 31, 2024
$ ( 1,476,823 )
$ ( 1,476,610 )
−Removed: funds attributable to common stock subject to redemption
−Removed: Remeasurement
−Removed: of ordinary shares subject to possible redemption
+Added: Extension funds attributable to ordinary shares subject to redemption
( 1,746,362 )
( 1,746,362 )
−Removed: as of December 31, 2024
+Added: Remeasurement of ordinary shares subject to possible redemption
( 1,895,527 )
( 1,895,527 )
−Removed: The Period From April 27, 2023 (Inception) to December 31, 2023
−Removed: Stockholders’
−Removed: Balance – April 27, 2023 (inception)
−Removed: Issuance of Founder Shares to Sponsor
−Removed: of public units through public offering
−Removed: of Private Placement Units
+Added: Balance as of December 31, 2025
$ ( 4,058,944 )
$ ( 4,058,731 )
−Removed: underwriting costs
−Removed: of representative shares
−Removed: shares subject to redemption
+Added: For the Year Ended December 31, 2024
+Added: Ordinary shares
+Added: Shareholders’
+Added: Balance as of December 31, 2023
$ ( 134,337 )
1 unchanged sentence
$ ( 134,337 )
−Removed: Remeasurement
−Removed: of ordinary shares subject to possible redemption
−Removed: of additional paid in capital to accumulated deficit
−Removed: – December 31, 2023
$ ( 134,124 )
+Added: Extension funds attributable to ordinary shares subject to redemption
+Added: Remeasurement of ordinary shares subject to possible redemption
( 3,617,001 )
( 3,617,001 )
+Added: Balance as of December 31, 2024
$ ( 1,476,823 )
+Added: $ ( 1,476,610 )
+Added: $ ( 1,476,823 )
+Added: $ ( 1,476,610 )
accompanying notes are an integral part of these financial statements.
1 unchanged sentence
OF CASH FLOWS
−Removed: Period from April 27, 2023
−Removed: Ended December 31, 2024
−Removed: through December 31, 2023
−Removed: Cash flows from operating
−Removed: Adjustments to reconcile net income to net
−Removed: cash used in operating activities:
−Removed: Interest earned in assets held in trust
+Added: For the Years Ended December 31,
+Added: Cash flows from operating activities:
+Added: Adjustments to reconcile net income to net cash used in operating activities:
+Added: Interest earned on cash held in trust
( 1,895,527 )
+Added: ( 3,617,001 )
Change in operating assets and liabilities:
−Removed: Formation costs paid by Sponsor under Promissory
−Removed: Note – Related Party
Prepaid expenses
1 unchanged sentence
Accrued expenses
−Removed: Net cash used in operating
−Removed: Cash flows from investing
+Added: Net cash used in operating activities
+Added: Cash flows from investing activities:
+Added: Cash withdrawn from Trust Account in connection with redemption
Extension payments deposited in Trust Account
−Removed: Investment of cash in
−Removed: Trust Account
( 1,746,362 )
−Removed: Net cash used in investing
−Removed: ( 69,690,000 )
−Removed: Cash flows from financing
−Removed: Proceeds from issuance of ordinary shares to
−Removed: Proceeds from sale of units through public
−Removed: Proceeds from sale of private placement units
−Removed: Proceeds from promissory note – related
−Removed: Proceeds from extension promissory note –
−Removed: related party
+Added: Net cash provided by (used in) investing activities
+Added: Cash flows from financing activities:
+Added: Proceeds from extension promissory note – related party
Advance from related party
−Removed: Payment of offering costs
+Added: Redemption of ordinary shares
( 65,326,328 )
−Removed: Repayment of promissory
−Removed: note – related party
−Removed: Net cash provided by financing
+Added: Net cash provided by (used in) financing activities
+Added: ( 63,040,145 )
NET CHANGE IN CASH
−Removed: CASH, BEGINNING OF PERIOD
−Removed: CASH, END OF PERIOD
−Removed: Non-cash investing and financing
−Removed: Deferred underwriting
−Removed: Initial classification
−Removed: of shares subject to redemption
−Removed: Remeasurement of ordinary
−Removed: stock subject to possible redemption
−Removed: Extension funds attributable
−Removed: to common stock subject to redemption
−Removed: Issuance of representative shares
−Removed: Accretion of additional
−Removed: paid-in capital to accumulated deficit
+Added: CASH, BEGINNING OF YEAR
+Added: CASH, END OF YEAR
+Added: Non-cash investing and financing activities
+Added: Remeasurement of ordinary shares subject to possible redemption
+Added: Extension funds attributable to ordinary shares subject to redemption
accompanying notes are an integral part of these financial statements.
1 unchanged sentence
TO FINANCIAL STATEMENTS
−Removed: 1 - ORGANIZATION AND BUSINESS BACKGROUND
+Added: 1 - ORGANIZATION, BUSINESS BACKGROUND AND GOING CONCERN
Health Technology Co., Ltd.
12 unchanged sentences
Since the Initial Public Offering, the Company’s activity has been
−Removed: limited to the evaluation of business combination candidates.
−Removed: The Company will not generate any operating revenue until after the completion
−Removed: of its initial business combination, at the earliest.
−Removed: The Company will generate non-operating income in the form of interest income on
−Removed: cash in bank and assets held in the Trust Account (as defined below) from the proceeds derived from the Initial Public Offering.
−Removed: Company has selected December 31 as its fiscal year end.
−Removed: The Company is an early stage and emerging growth company and, as such, the
−Removed: Company is subject to all of the risks associated with early stage and emerging growth companies.
+Added: limited to the costs incurred in pursuit of the consummation of an initial business combination.
+Added: The Company will not generate any operating
+Added: revenue until after the completion of its initial business combination, at the earliest.
+Added: The Company will generate non-operating income
+Added: in the form of interest income on cash in bank and cash held in the Trust Account (as defined below) from the proceeds derived from the
+Added: Initial Public Offering.
+Added: The Company has selected December 31 as its fiscal year end.
+Added: The Company is an early stage and emerging growth
+Added: company and, as such, is subject to all of the risks associated with early stage and emerging growth companies.
Company’s sponsor is Aimei Investment Ltd, a Cayman Islands exempted company (the “Sponsor”).
13 unchanged sentences
(the “Private Units”) to the Sponsor at a price of $ 10.00 per Unit, generating total gross proceeds of $ 3,320,000 (the “Private
−Removed: (see Note 4).
+Added: Placement”) (see Note 4).
the closing of the Initial Public Offering on December 6, 2023, an amount of $ 69,690,000 ($ 10.10 per Unit) from the net proceeds of the
22 unchanged sentences
of a business combination with respect to the Company’s rights.
−Removed: HEALTH TECHNOLOGY CO., LTD
−Removed: TO FINANCIAL STATEMENTS
a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other reasons, the Company
7 unchanged sentences
in connection with a shareholder vote to approve a proposed initial business combination or any amendment to the Company’s charter
−Removed: prior to the consummation of its initial business combination and (iii) not to sell any shares to the Company in a tender offer in connection
+Added: prior to the consummation of its initial business combination and (iii) not to sell any shares to us in a tender offer in connection
with any proposed business combination.
45 unchanged sentences
contemplated by the Merger Agreement (the “Closing”), the representative for the Company and its shareholders (the “Sponsor”).
−Removed: HEALTH TECHNOLOGY CO., LTD
−Removed: TO FINANCIAL STATEMENTS
to the Merger Agreement, subject to the terms and conditions set forth therein, (i) First Merger Sub will merge with and into the United
5 unchanged sentences
of Second Merger Sub will cease, and the Company will be the surviving corporation of the Second Merger as a wholly-owned subsidiary
−Removed: February 6, 2025, the Company entered into an amendment (the “Trust Agreement Amendment”) to the Investment Management Trust
−Removed: Agreement with Continental Stock Transfer & Trusts Company (“Trustee”).
−Removed: Pursuant to the Trust Agreement Amendment, the
−Removed: amount of funds to be deposited into the trust account managed by the Trustee (the “Trust Account”) in connection with extending
−Removed: the timeframe within which the Company must consummate its initial business combination (“Extension”), is adjusted from $ 0.033
−Removed: per each share sold in its IPO (the “Public Share”) (for each monthly extension) to an amount equal to $ 150,000 for all outstanding
−Removed: Public Shares (for each monthly extension).
−Removed: of the date of this report, the Company has extended four times by an additional one month each time, and so it now has until April 6,
−Removed: 2025 to consummate a business combination.
−Removed: Pursuant to the terms of the current amended and restated memorandum and articles of association
−Removed: and the trust agreement between the Company and Continental Stock Transfer & Trust Company, LLC, in order to extend the time available
−Removed: for the Company to consummate its initial business combination, the Company’s insiders or their affiliates or designees, must deposit
−Removed: into the Trust Account $ 150,000 on or prior to the date of the applicable deadline.
−Removed: On each of December 11, 2024 and January 13, 2025,
−Removed: the Company has deposited $ 227,700 into the Trust Account in order to extend the amount of available time to complete a business combination
−Removed: until February 6, 2025.
−Removed: On each of February 6, 2025 and March 6, 2025, the Company has deposited in an amount of $ 150,000 into the Trust
−Removed: Account in order to extend the amount of available time to complete a business combination until April 6, 2025.
+Added: February 5, 2025, in connection with the stockholders vote at the Company’s previous adjourned extraordinary general meeting (“ Adjourned
+Added: Meeting ”), 2,904,267 shares were redeemed by certain shareholders at a price of approximately $ 10.77 per share, including
+Added: interest generated and extension payments deposited in the Trust Account, in an aggregate amount of approximately $ 31.27 million.
+Added: February 6, 2025, the Company entered into an amendment (the “ Trust Agreement Amendment ”) to the Investment
+Added: Management Trust Agreement with Continental Stock Transfer & Trust Company (“ Trustee ”).
+Added: Pursuant to the
+Added: Trust Agreement Amendment, the amount of funds to be deposited into the trust account managed by the Trustee (the “ Trust
+Added: Account ”) in connection with extending the timeframe within which the Company must consummate its initial business combination
+Added: (“ Extension ”), is adjusted from $ 0.033 per each share sold in its IPO (the “ Public Share ”)
+Added: (for each monthly extension) to an amount equal to $ 150,000 for all outstanding Public Shares (for each monthly extension).
+Added: December 2, 2025, the Company entered into an amendment (the “ Trust Agreement Amendment ”) to the Investment
+Added: Management Trust Agreement with Continental Stock Transfer & Trust Company (“ Trustee ”).
+Added: Pursuant to the
+Added: Trust Agreement Amendment, the amount of funds to be deposited into the trust account managed by the Trustee (the “ Trust
+Added: Account ”) in connection with extending the timeframe within which the Company must consummate its initial business combination
+Added: (“ Extension ”), is adjusted from $ 150,000 for all outstanding ordinary shares sold in its IPO (the “ Public
+Added: Shares ”) (for each monthly extension), to an amount equal to the lesser of (i) $ 80,000 for all outstanding Public Shares
+Added: and (ii) $ 0.033 for each outstanding Public Share for each monthly extension.
+Added: December 2, 2025, in connection with the approval of the Article Amendment Proposal and the Trust Agreement Amendment Proposal at the
+Added: Extraordinary General Meeting, 2,955,401 shares were redeemed by certain shareholders at a price of approximately $ 11.52 per share, including
+Added: interest generated and extension payments deposited in the Trust Account, in an aggregate amount of approximately $ 34.06 million.
+Added: Company has exercised multiple one-month extensions to extend the time to consummate a business combination.
+Added: Pursuant to the terms of
+Added: the current amended and restated memorandum and articles of association and the trust agreement between the Company and the Trustee,
+Added: in order to extend the time available for the Company to consummate its initial business combination, the Company’s insiders or
+Added: their affiliates or designees, must deposit into the Trust Account a monthly extension fee on or prior to the date of the applicable
+Added: During the years ended December 31, 2025 and 2024, the Sponsor and United Hydrogen funded a series of monthly extension payments
+Added: to the Trust Account in order to extend the period available to consummate a business combination.
+Added: The extension payments are funded
+Added: by unsecured, non-interest-bearing convertible extension loans issued by the Company (see Note 5).
and Capital Resources
of December 31, 2025, the Company had $ 2,929 in its bank account, $ 12,100,110 in its Trust Account and working capital deficit of $ 3,368,731 .
−Removed: Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through (i) the payment of $ 25,000
−Removed: from the Sponsor to cover certain offering costs on the Company’s behalf in exchange for issuance of Founder Shares (see Note 5),
−Removed: and (ii) a loan from the Sponsor of approximately $ 210,151 under the Note (as defined in Note 5).
−Removed: The Company has repaid the note in
−Removed: full on December 7, 2023.
−Removed: Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied
−Removed: through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account.
−Removed: In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor,
−Removed: or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as
−Removed: defined in Note 5).
−Removed: As of December 31, 2024, there were no amounts outstanding under any Working Capital Loan.
+Added: Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private
+Added: Placement held outside of the Trust Account.
+Added: In addition, in order to finance transaction costs in connection with a business combination,
+Added: the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide
+Added: the Company Working Capital Loans (as defined in Note 5).
+Added: As of December 31, 2025, there were no amounts outstanding under any Working
+Added: Capital Loan.
the period of time to complete a business combination, the Company will be using the funds held outside of the Trust Account for paying
2 unchanged sentences
negotiating and consummating the business combination.
−Removed: HEALTH TECHNOLOGY CO., LTD
−Removed: TO FINANCIAL STATEMENTS
Concern Consideration
3 unchanged sentences
from the closing of the Initial Public Offering, the requirement that the Company cease all operations, redeem the Public Shares, and
−Removed: thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern.
−Removed: The financial statements
−Removed: do not include any adjustments that might result from the outcome of this uncertainty.
−Removed: The accompanying financial statements have been
−Removed: prepared in conformity with generally accepted accounting principles in the U.S.
−Removed: GAAP”), which contemplate continuation
−Removed: of the Company as a going concern.
+Added: thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern within one year after the
+Added: date that the financial statements are issued.
+Added: There is no assurance that the Company’s plans to consummate a business combination
+Added: will be successful by the Combination Deadline.
+Added: The financial statements do not include any adjustments that might result from the outcome
+Added: of this uncertainty.
+Added: The accompanying financial statements have been prepared in conformity with accounting principles generally accepted
+Added: in the United States of America (“U.S.
+Added: GAAP”), which contemplate continuation of the Company as a going concern.
2 – SIGNIFICANT ACCOUNTING POLICIES
1 unchanged sentence
accompanying financial statements have been prepared in accordance with U.S.
−Removed: GAAP and pursuant to the rules and regulations of the SEC.
+Added: GAAP and pursuant to the rules and regulations of the Securities
+Added: and Exchange Commission (“SEC”).
growth company
26 unchanged sentences
could differ significantly from those estimates.
−Removed: HEALTH TECHNOLOGY CO., LTD
−Removed: TO FINANCIAL STATEMENTS
and cash equivalents
4 unchanged sentences
held in trust account
−Removed: July 16, 2024, the Company instructed their trust custodian to liquidate their positions in marketable securities and invest 100% of
−Removed: the trust account in an interest-bearing demand deposit account.
−Removed: As of December 31, 2024, all the assets held in the Trust Account were
−Removed: held in an interest-bearing demand deposit account.
−Removed: As of December 31, 2023, substantially all the assets held in the Trust Account were
−Removed: Treasury Bills.
−Removed: The Company accounts for its marketable securities under ASC 320, where securities are presented at fair
−Removed: value on the balance sheets and with gains or losses, if any, presented on the statements of operations.
−Removed: As of December 31, 2024 and
−Removed: 2023, the assets held in Trust Account was $ 73,784,549 and $ 69,889,848 , respectively.
+Added: July 16, 2024, the Company instructed its trust custodian to liquidate its positions in marketable securities and invest 100% of the
+Added: trust account in an interest-bearing demand deposit account.
+Added: As of December 31, 2025 and 2024, all the cash held in the Trust Account
+Added: was held in an interest-bearing demand deposit account.
+Added: Interest earned is included in the interest earned on cash held in trust in the
+Added: accompanying statements of operations.
+Added: As of December 31, 2025 and 2024, the cash held in the Trust Account was $ 12,100,110 and $ 73,784,549 ,
+Added: respectively.
shares subject to possible redemption
1 unchanged sentence
the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer
−Removed: in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate
−Removed: of incorporation.
−Removed: In accordance with Accounting Standards Codification (“ASC”) 480 “ Distinguishing Liabilities from
−Removed: Equity ”, conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either
+Added: in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated memorandum
+Added: and articles of association.
+Added: In accordance with Accounting Standards Codification (“ASC”) 480, “ Distinguishing Liabilities
+Added: from Equity ,” conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either
within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s
31 unchanged sentences
As such, there was no provision
−Removed: for income taxes for the years ended December 31, 2024 and 2023.
−Removed: HEALTH TECHNOLOGY CO., LTD
−Removed: TO FINANCIAL STATEMENTS
+Added: for income taxes for the years ended December 31, 2025 and 2024, respectively.
income per share
income per share is computed by dividing net income by the weighted average number of ordinary shares outstanding for the period.
−Removed: calculation of diluted loss per share does not consider the effect of the rights issued in connection with the Initial Public Offering
−Removed: and rights issued as components of the Private Units (the “Private Rights”) since the issuance of shares underlying the rights
−Removed: is contingent upon the occurrence of future events.
−Removed: As a result, diluted loss per share is the same as basic loss per share for the periods.
+Added: The calculation of diluted income per share does not consider the effect of the rights issued in connection with the Initial
+Added: Public Offering and rights issued as components of the Private Units (the “Private Rights”) since the issuance of shares
+Added: underlying the rights is contingent upon the occurrence of future events.
+Added: As a result, diluted income per share is the same as
+Added: basic income per share for the periods.
following table reflects the calculation of basic and diluted net income per ordinary share:
−Removed: OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE
+Added: SCHEDULE OF BASIC AND DILUTED NET INCOME PER ORDINARY SHARE
December 31, 2025
−Removed: from April 27, 2023 (inception) to
December 31, 2024
−Removed: including accretion of carrying value to redemption value
−Removed: Non-Redeemable
−Removed: Non-Redeemable
+Added: Net income including accretion of carrying value to redemption value
For the Year ended
−Removed: Period from April 27, 2023 (inception)
+Added: For the Year ended
+Added: December 31, 2025
+Added: December 31, 2024
Non-Redeemable
Non-Redeemable
+Added: Ordinary Share
+Added: Ordinary Share
+Added: Ordinary Share
+Added: Ordinary Share
Basic and diluted net income per share:
−Removed: of net income
+Added: Allocation of net income
Denominators:
Weighted-average shares outstanding
−Removed: Basic and diluted net
−Removed: income per share
+Added: Basic and diluted net income per share
Concentration
4 unchanged sentences
experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
−Removed: As of December
−Removed: 31, 2024 and 2023, $ 0 and $ 330,717 was not insured, respectively.
value of financial instruments
−Removed: fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
−Removed: between market participants at the measurement date.
−Removed: GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
−Removed: used in measuring fair value.
−Removed: The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
−Removed: or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
+Added: fair value is defined as the price that would be received for the sale of an asset or paid for the transfer of a liability in an orderly
+Added: transaction between market participants at the measurement date.
+Added: GAAP establishes a three-tier fair value hierarchy, which prioritizes
+Added: the inputs used in measuring fair value.
+Added: The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical
+Added: assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
These tiers include:
−Removed: HEALTH TECHNOLOGY CO., LTD
−Removed: TO FINANCIAL STATEMENTS
1 — defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
−Removed: 2 — defined as inputs other than quoted prices in active markets that are either directly
−Removed: or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar
−Removed: instruments in markets that are not active;
−Removed: 3 — defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own
−Removed: assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers
−Removed: are unobservable.
+Added: 2 — defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
+Added: prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
+Added: 3 — defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
+Added: such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy.
3 unchanged sentences
31, 2025 and 2024 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair
−Removed: OF FAIR VALUE HIERARCHY VALUATION TECHNIQUES
−Removed: Quoted Prices
−Removed: In Active Markets
−Removed: in trust account
−Removed: Quoted Prices
−Removed: In Active Markets
−Removed: marketable securities held in Trust Account
+Added: SCHEDULE OF FAIR VALUE HIERARCHY VALUATION TECHNIQUES
+Added: Quoted Prices In Active Markets
+Added: Significant Other
+Added: Observable Inputs
+Added: Significant Other
+Added: Unobservable Inputs
+Added: Cash held in trust account
+Added: Quoted Prices In Active Markets
+Added: Significant Other
+Added: Observable Inputs
+Added: Significant Other
+Added: Unobservable Inputs
+Added: Cash held in trust account
which can be a corporation or individual, are considered to be related if either the Company or the other party has the ability, directly
2 unchanged sentences
issued accounting standards
−Removed: November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280):
−Removed: Improvements to Reportable Segment Disclosures.
−Removed: The amendments
−Removed: in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief
−Removed: operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported
−Removed: measure of segment profit or loss.
−Removed: The ASU requires that a public entity disclose the title and position of the CODM and an explanation
−Removed: of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate
−Removed: Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and
−Removed: entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing
−Removed: segment disclosures in Topic 280.
−Removed: This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within
−Removed: fiscal years beginning after December 15, 2024, with early adoption permitted.
−Removed: does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material
−Removed: effect on the Company’s financial statements.
−Removed: HEALTH TECHNOLOGY CO., LTD
−Removed: TO FINANCIAL STATEMENTS
+Added: does not believe that any recently issued, or recently issued but not effective, accounting standards, if currently adopted, would
+Added: have a material effect on the Company’s financial statements.
3 – INITIAL PUBLIC OFFERING
4 unchanged sentences
one-fifth (1/5) of one ordinary share upon consummation of the Company’s initial business combination, so the holder must hold
−Removed: rights in multiples of 5 in order to receive shares for all of the rights upon closing of a business combination.
+Added: rights in multiples of five in order to receive shares for all of the rights upon closing of a business combination.
4 – PRIVATE PLACEMENT
2 unchanged sentences
Private Unit ($ 3,320,000 in the aggregate).
−Removed: proceeds from the sale of the Private Units will be added to the net proceeds from the Offering held in the Trust Account.
−Removed: Units are identical to the Units sold in the Initial Public Offering except that Private Units (including the Private Rights) will not
−Removed: be transferable, assignable or saleable until the completion of the Company’s initial business combination except to permitted
−Removed: If the Company does not complete a business combination within the Combination Period, the proceeds from the sale of the
−Removed: Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private
−Removed: Rights will expire worthless.
+Added: proceeds from the sale of the Private Units were added to the net proceeds from the Offering held in the Trust Account.
+Added: Units are identical to the Units sold in the Initial Public Offering except that Private Units (including the Private Rights) are
+Added: not transferable, assignable or saleable until the completion of the Company’s initial business combination except to
+Added: permitted transferees.
+Added: If the Company does not complete a business combination within the Combination Period, the proceeds from the
+Added: sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law)
+Added: and the Private Rights will expire worthless.
5 – RELATED PARTY TRANSACTIONS
19 unchanged sentences
to certain limited exceptions, the initial shareholders have agreed not to transfer, assign, or sell their founder shares until six months
−Removed: after the date of the consummation of the Company’s initial business combination or earlier if, subsequent to initial business
−Removed: combination, the Company consummate a subsequent liquidation, merger, share exchange or other similar transaction which results in all
+Added: after the date of the consummation of the Company’s initial business combination or earlier if, subsequent to the initial business
+Added: combination, the Company consummates a subsequent liquidation, merger, share exchange, or other similar transaction that results in all
of the shareholders having the right to exchange their ordinary shares for cash, securities, or other property.
−Removed: Note – Related Party
−Removed: May 1, 2023, the Sponsor issued an unsecured promissory note (the “Note”) to the Company, pursuant to which the Company may
−Removed: borrow up to an aggregate principal amount of $ 750,000 , to be used for payment of costs related to the Initial Public Offering.
−Removed: is non-interest bearing and payable on the earlier of (i) December 31, 2023, (ii) the consummation of the Initial Public Offering, or
−Removed: (iii) the date on which the Company determines to not proceed with the Initial Public Offering.
−Removed: These amounts were repaid upon completion
−Removed: of the Initial Public Offering out of the $ 550,000 of Initial Public Offering proceeds that has been allocated for the payment of Initial
−Removed: Public Offering expenses.
−Removed: As of December 6, 2023, the Company has borrowed $ 210,151 under the Note.
−Removed: The Note was fully repaid on December
−Removed: There was no outstanding balance due as of December 31, 2024 and 2023.
−Removed: HEALTH TECHNOLOGY CO., LTD
−Removed: TO FINANCIAL STATEMENTS
Loan – Related Party
−Removed: Company will have to consummate a business combination by April 6, 2025.
−Removed: However, if the Company anticipates that it may not be able
−Removed: to consummate a business combination within 12 months, the Company may extend the period of time to consummate a business combination
−Removed: up to twelve times by an additional one month each time to complete a business combination.
−Removed: Pursuant to the terms of the Company’s
−Removed: memorandum and articles of association and the trust agreement entered into between the Company and Continental Stock Transfer &
−Removed: Trust Company, both as amended, in order to extend the time available for the Company to consummate a business combination, the Sponsor
−Removed: its affiliates or designees, upon five days advance notice prior to the applicable deadline, must deposit into the Trust Account the
−Removed: applicable extension fees, on or prior to the date of the applicable deadline, for each extension.
−Removed: The Sponsor or its affiliates or designees
−Removed: will receive a non-interest bearing, unsecured promissory note equal to the amount of any such deposit that will not be repaid in the
−Removed: event that the Company are unable to close a business combination unless there are funds available outside the Trust Account to do so.
−Removed: Such notes would either be paid upon consummation of the Company’s initial business combination or at the lender’s discretion,
−Removed: converted upon consummation of the business combination into additional private units at a price of $ 10.00 per unit.
−Removed: December 11, 2024, the Company issued an unsecured promissory note in the amount of $ 227,700 to the Sponsor and United Hydrogen, pursuant
−Removed: to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business
−Removed: combination until January 6, 2025.
−Removed: The notes are non-interest bearing and are payable upon the closing of a business combination.
−Removed: addition, the notes may be converted, at the lender’s discretion, into additional Private Units at a price of $ 10.00 per unit.
−Removed: As of December 31, 2024 and 2023, the note payable balance was $ 227,700 and $ 0 , respectively.
+Added: to the amended and restated memorandum and articles of association of the Company then in effect, if the Company anticipates that it
+Added: may not be able to consummate a business combination within 12 months of the closing of the IPO, the Company may extend the period of
+Added: time to consummate a business combination up to twelve times by an additional one month each time to complete a business combination.
+Added: Pursuant to the terms of the Company’s memorandum and articles of association and the trust agreement entered into between the
+Added: Company and the Trustee, both as amended, in order to extend the time available for the Company to consummate a business combination,
+Added: the Sponsor its affiliates or designees, upon five days advance notice prior to the applicable deadline, must deposit into the Trust
+Added: Account the applicable extension fees, on or prior to the date of the applicable deadline, for each extension.
+Added: The Sponsor or its affiliates
+Added: or designees will receive a non-interest bearing, unsecured promissory note equal to the amount of any such deposit that will not be
+Added: repaid in the event that the Company is unable to close a business combination unless there are funds available outside the Trust Account
+Added: Such notes would either be paid upon consummation of the Company’s initial business combination or at the lender’s
+Added: discretion, converted upon consummation of the business combination into additional private units at a price of $ 10.00 per unit.
+Added: the years ended December 31, 2025 and 2024, the Company entered into monthly extension loans with its Sponsor for $ 1,012,031 and $ 113,850 ,
+Added: respectively, and United Hydrogen for $ 1,012,031 and $ 113,850 , respectively;
+Added: these funds were deposited into the Trust Account in order
+Added: to extend the time available to complete a business combination.
+Added: These loans are non-interest-bearing, payable upon the closing of a
+Added: business combination, and convertible, at the lender’s discretion, upon consummation of the business combination, into additional
+Added: private units at a price of $ 10.00 per unit.
+Added: As of December 31, 2025 and 2024, the extension loan balances were $ 2,024,062 and $ 227,700 ,
+Added: respectively.
+Added: Capital Loans
order to finance transaction costs in connection with a business combination, the Company’s Sponsor or an affiliate of the Sponsor,
11 unchanged sentences
to a related company
−Removed: of December 31, 2024 and 2023, the Company had a total amount due to related company of $ 289,780 and $ 0 from a related party, respectively,
−Removed: for the payment of costs related to general and administrative services, the Initial Public Offering and administrative services agreement.
−Removed: The balance of which $ 50,000 was deposited in the trust account as of December 31, 2024 for the January 13, 2025 extension payment.
−Removed: balance is unsecured, interest-free and has no fixed terms of repayment.
+Added: of December 31, 2025 and 2024, the Company had a total amount due to related company of $ 899,601 and $ 289,780 , respectively, for the
+Added: payment of costs related to general and administrative services.
+Added: The balance is unsecured, interest-free and has no fixed terms of repayment.
Administrative
4 unchanged sentences
The Company has
−Removed: agreed to pay to the Sponsor, $ 10,000 per month, for up to 12 months, subject to extension to up to 24 months, as provided in the Company’s
+Added: agreed to pay the Sponsor $ 10,000 per month, for up to 12 months, subject to extension to up to 24 months, as provided in the Company’s
registration statement, for such administrative services.
−Removed: As of December 31, 2024 and 2023, the unpaid balance was $ 120,000 and $ 0 , respectively,
−Removed: which is included in amount due to related company balance.
−Removed: HEALTH TECHNOLOGY CO., LTD
−Removed: TO FINANCIAL STATEMENTS
+Added: As of December 31, 2025 and 2024, the unpaid balance was $ 240,000 and $ 120,000 ,
+Added: respectively, which is included in the amount due to related company balance.
+Added: This agreement expired on December 31, 2025, and is no
+Added: longer in effect;
+Added: the Sponsor is providing office space to the Company free of charge.
6 – SHAREHOLDERS’ DEFICIT
2 unchanged sentences
shares are entitled to one vote for each share.
−Removed: On May 1, 2023, The Company entered into a subscription agreement for founder shares
−Removed: with the Sponsor which is recorded as subscription receivable.
−Removed: The subscription agreement was amended and restated on May 24, 2023.
−Removed: to the Initial Public Offering, the Company issued an aggregate of 50,000 ordinary shares of $ 1.00 par value each to Han Huang.
−Removed: 11, 2023, Han Huang transferred those ordinary shares to the Sponsor and on May 15, 2023, the Sponsor resolved to sub-divide the ordinary
−Removed: shares of $ 1.00 par value each into ordinary shares of $ 0.0001 par value each and as such the Sponsor held 500,000,000 ordinary shares
−Removed: of $ 0.0001 each.
−Removed: On May 15, 2023, the directors resolved to repurchase 498,562,500 ordinary shares from the Sponsor, the repurchase resulting
−Removed: in the Sponsor holding 1,437,500 ordinary shares.
−Removed: On May 25, 2023, 1,437,500 founder shares were issued to the Sponsor pursuant to a
−Removed: securities subscription agreement for an aggregate purchase price of $ 25,000 (up to 187,500 of which are subject to forfeiture depending
−Removed: on the extent to which the underwriters’ over-allotment option is exercised) pursuant to a securities subscription agreement and
−Removed: the 1,437,500 ordinary shares previously held by the Sponsor were repurchased by the Company, the shares having been retroactively adjusted.
−Removed: As of May 8, 2023, $ 25,000 was included as a subscription receivable.
−Removed: On September 15, 2023, the Company received $ 25,000 in cash.
−Removed: Sponsor transferred 152,000 of those ordinary shares among the Company’s Chief Executive Officer, Chief Financial Officer and three
−Removed: independent director nominees at their original purchase price pursuant to executed securities assignment agreements, effective as of
−Removed: May 25, 2023.
−Removed: On October 20, 2023, the Company capitalized an amount equal to $ 28.75 standing to the credit of the share premium account
−Removed: and appropriated such sum and applied it on behalf of the Sponsor towards paying up in full (as to the full par value of $ 0.0001 per
−Removed: founder share) 287,500 unissued ordinary shares of $ 0.0001 par value and allotted such shares credited as fully paid to the Sponsor,
−Removed: resulting in 1,725,000 ordinary shares being issued and outstanding.
−Removed: 225,000 shares of such ordinary shares are not subject to forfeiture
−Removed: as the underwriters’ over-allotment was exercised in full.
−Removed: The initial shareholders will collectively own approximately 20 % of
−Removed: the Company’s issued and outstanding shares after the Initial Public Offering (assuming the initial shareholders do not purchase
−Removed: any Public Shares in the Initial Public Offering and excluding the Private Units and underlying securities).
−Removed: of December 31, 2024 and 2023, as a result of the closing of the Initial Public Offering and full exercise of the underwriters’
−Removed: over-allotment option, there were 2,126,000 ordinary shares issued and outstanding, excluding 6,900,000 ordinary shares subject to possible
+Added: the year ended December 31, 2025, 5,859,668
+Added: ordinary shares were redeemed for approximately $ 65.33
+Added: There were no
+Added: ordinary shares redeemed in the year ended December 31, 2024.
+Added: of December 31, 2025 and 2024, there were 2,126,000 ordinary shares issued and outstanding, excluding 1,040,332 and 6,900,000 ordinary
+Added: shares subject to possible redemption, respectively.
holder of a right will receive one-fifth (1/5) of one ordinary share upon consummation of a business combination, even if the holder
7 unchanged sentences
Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share
−Removed: consideration the holders of the ordinary share will receive in the transaction on an as-converted into ordinary share basis and each
−Removed: holder of a right will be required to affirmatively convert its rights in order to receive 1/5th of one share underlying each right (without
−Removed: paying additional consideration).
−Removed: The shares issuable upon exchange of the rights will be freely tradable (except to the extent held
−Removed: by affiliates of the Company).
+Added: consideration the holders of the ordinary shares will receive in the transaction on an as-converted into ordinary share basis, and each
+Added: holder of a right will be required to affirmatively convert its rights in order to receive one-fifth (1/5) of one share underlying each
+Added: right (without paying additional consideration).
+Added: The shares issuable upon exchange of the rights will be freely tradable (except to the
+Added: extent held by affiliates of the Company).
Additionally,
5 unchanged sentences
Accordingly, the rights may expire worthless.
−Removed: HEALTH TECHNOLOGY CO., LTD
−Removed: TO FINANCIAL STATEMENTS
7 – COMMITMENTS AND CONTINGENCIES
27 unchanged sentences
of sales in the Initial Public Offering pursuant to FINRA Rule 5110(e)(1).
−Removed: Pursuant to FINRA Rule 5110(e)(1), these securities will
−Removed: not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the
+Added: Pursuant to FINRA Rule 5110(e)(1), these securities will not
+Added: be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the economic disposition of the
securities by any person for a period of 180 days immediately following the date of the commencement of sales in the Initial Public Offering,
−Removed: nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the date of the commencement
−Removed: of sales in the Initial Public Offering except to any underwriter and selected dealer participating in the offering and their officers,
−Removed: partners, registered persons or affiliates.
+Added: nor may they be sold, transferred, assigned, pledged, or hypothecated for a period of 180 days immediately following the date of the
+Added: commencement of sales in the Initial Public Offering except to any underwriter and selected dealer participating in the offering and
+Added: their officers, partners, registered persons, or affiliates.
underwriters purchased 900,000 additional Units to cover over-allotments.
−Removed: underwriters were entitled to a cash underwriting discount of:
−Removed: (i) two percent ( 2.00 %) of the gross proceeds of the Initial Public Offering,
−Removed: or $ 1,380,000 as the underwriters’ over-allotment is exercised in full.
+Added: underwriters were entitled to a cash underwriting discount of two percent ( 2.00 %) of the gross proceeds of the Initial Public Offering,
+Added: or $ 1,380,000 , as the underwriters’ over-allotment was exercised in full.
In addition, the underwriters are entitled to a deferred
fee of one percent ( 1.0 %) of the gross proceeds of the Initial Public Offering, or $ 690,000 , as the underwriters’ over-allotment
−Removed: is exercised in full upon closing of the business combination.
−Removed: The deferred fee will be paid in cash upon the closing of a business combination
−Removed: from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.
−Removed: In addition, the Company has paid the
−Removed: representative of the underwriters, at the closing of the Initial Public Offering, 1.00 % of the gross proceeds in the Company’s
−Removed: ordinary shares or 69,000 ordinary shares as the underwriters’ over-allotment is exercised in full.
+Added: was exercised in full, upon closing of the business combination.
+Added: The deferred fee will be paid in cash upon the closing of a business
+Added: combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.
+Added: In addition, the Company
+Added: paid the representative of the underwriters, at the closing of the Initial Public Offering, 1.00 % of the gross proceeds in the Company’s
+Added: ordinary shares, or 69,000 ordinary shares, as the underwriters’ over-allotment was exercised in full.
of First Refusal
4 unchanged sentences
from the commencement of sales in the Initial Public Offering.
−Removed: HEALTH TECHNOLOGY CO., LTD
−Removed: TO FINANCIAL STATEMENTS
8 – SEGMENT INFORMATION
8 unchanged sentences
evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics,
−Removed: which includes general and administrative expenses and interest earned on assets held in Trust Account which are included in the accompanying
+Added: which include general and administrative expenses and interest earned on cash held in the Trust Account which are included in the accompanying
statements of operations.
−Removed: key measures of segment profit or loss reviewed by our CODM are earned on assets held in Trust Account and general and administrative
−Removed: The CODM reviews earned on assets held in Trust Account to measure and monitor stockholder value and determine the most effective
−Removed: strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement.
−Removed: General and administrative
−Removed: expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business
−Removed: combination within the business combination period.
−Removed: The CODM also reviews general and administrative costs to manage, maintain and enforce
−Removed: all contractual agreements to ensure costs are aligned with all agreements and budget.
+Added: key measures of segment profit or loss reviewed by our CODM are interest earned on cash held in the Trust Account and general and
+Added: administrative expenses.
+Added: The CODM reviews interest earned on cash held in the Trust Account to measure and monitor
+Added: stockholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance
+Added: with the trust agreement.
+Added: General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to
+Added: ensure enough capital is available to complete a business combination within the business combination period.
+Added: The CODM also reviews
+Added: general and administrative costs to manage, maintain, and enforce all contractual agreements to ensure costs are aligned with all
+Added: agreements and budget.
9 – SUBSEQUENT EVENTS
2 unchanged sentences
sheet date through the date the financial statements were issued.
−Removed: January 13, 2025, the Company issued an unsecured promissory note in an amount of $ 227,700 to the Sponsor and United Hydrogen, pursuant
−Removed: to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business
−Removed: combination until February 6, 2025.
−Removed: February 5, 2025, in connection with the stockholders vote at the Adjourned Meeting, 2,904,267 shares were redeemed by certain shareholders
−Removed: at a price of approximately $ 10.77 per share, including interest generated and extension payments deposited in the Trust Account, in
−Removed: an aggregate amount of approximately $ 31.27 million.
−Removed: February 6, 2025, the Company entered into the Trust Agreement Amendment with the Trustee.
−Removed: Pursuant to the Trust Agreement Amendment,
−Removed: the amount of funds to be deposited into the Trust Account in connection with extending the timeframe within which the Company must consummate
−Removed: its initial business combination, is adjusted from $ 0.033 per each Public Share (for each monthly extension) to an amount equal to $ 150,000
−Removed: for all outstanding Public Shares (for each monthly extension).
−Removed: February 6, 2025, the Company issued an unsecured promissory note in an amount of $ 150,000 to the Sponsor and United Hydrogen, pursuant
−Removed: to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business
−Removed: combination until March 6, 2025.
−Removed: March 6, 2025, the Company issued an unsecured promissory note in an amount of $ 150,000 to the Sponsor and United Hydrogen, pursuant
−Removed: to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business
−Removed: combination until April 6, 2025.
+Added: to December 31, 2025, the Company entered into monthly extension loans with its Sponsor for $ 17,165
+Added: and United Hydrogen for $ 17,165 each month ,
+Added: which are deposited into the Trust Account in order to extend the time available to complete a business combination through January
+Added: 5, 2026, February 12, 2026, March 4, 2026, April 7, 2026 and May 7, 2026.
+Added: These loans are non-interest-bearing, payable upon the closing of a
+Added: business combination, and convertible, at the lender’s discretion, upon consummation of the business combination, into
+Added: additional private units at a price of $ 10.00
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.